Medical Data Harmonization via Provider Stratification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current systems lack the ability to efficiently aggregate and analyze genomic, patient phenotypic, and clinical data from disparate sources, leading to challenges in identifying and addressing abnormal prescribing behaviors among medical professionals, which can skew analysis and impact drug development and precision medicine efforts.

Innovation Solution

A medical data analysis system that automatically collects, harmonizes, and analyzes data to identify abnormal prescribing behaviors by generating models of expected prescribing behaviors based on clinical guidelines, stratifying medical service providers, and determining the influence of demographic and practice demographic data points on prescribing practices.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If patient data is aggregated from disparate sources, then the quantity and diversity of available data increases, but the complexity of harmonizing and analyzing the data increases

Engineering Contradiction:
Improvequantity of patient dataVSAvoidcomplexity of data harmonization system
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The system segments patient data from disparate sources into standardized categories and structures, breaking down the complex harmonization task into manageable components that can be processed systematically across multiple data sources

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system creates a universal data harmonization framework that can process and standardize patient data from multiple different sources simultaneously, enabling one system to handle diverse data types and formats through common processing mechanisms

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If prescribing behaviors are analyzed without stratification, then the analysis process is simpler, but the precision of identifying abnormal behaviors decreases

Engineering Contradiction:
Improveprecision of abnormal prescribing behavior identificationVSAvoidcomplexity of stratified analysis system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments medical service providers into distinct strata based on patient demographic characteristics, allowing abnormal prescribing behaviors to be identified within specific groups rather than across the entire population, thereby improving detection precision

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system applies different analysis criteria and expectations to different strata of medical service providers based on their specific patient populations and practice characteristics, enabling more accurate identification of abnormal behaviors tailored to each group's context

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20230368883A1System and methods for harmonizing and analyzing medical data
Publication Date: 2023.11.16 MEDALYNX INC
  • US20230368883A1 patent drawing
  • US20230368883A1 patent drawing
  • US20230368883A1 patent drawing

AI summary

A medical data analysis system and associated methods are disclosed for automatically and dynamically collecting, harmonizing and analyzing medical data to identify and address abnormal prescribing behaviors. In at least one embodiment, upon a user desiring to obtain an analysis of a given medical condition, a model of expected prescribing behaviors for said medical condition is generated. Medical service providers stored within the system are stratified into a plurality of groups. A model of average prescribing behaviors for said medical condition is generated for each of the stratified groups of medical service providers. Upon determining that a given stratified group does not approximate the model of expected prescribing behaviors for said medical condition, the stratified group is identified as containing abnormal prescribing behaviors, and it is then determined which of the associated patient demographic and/or practice demographic data points had the strongest influence on the abnormal prescribing behaviors.